Advertisement
Advertisement
CORT
Corcept Therapeutics Inc.
43.90
USDSponsored
+0.22
+0.50%
Apr 15, 16:00 UTC -4
Closed
After-Market
44.26
+0.36
+0.81%
Corcept Therapeutics Inc. Financial Snapshot
| Market Cap | 4.71B |
| Beta | 0.25 |
| Earnings Per Share (EPS) | 0.82 |
| Price-to-Book (P/B) Ratio | 6.86 |
| Operating Margin | 12.96% |
| Total Debt/Equity (D/E) | 0.78% |
| P/E Ratio | 51.52 |
| Return on Equity (ROE) | 15.19% |
| Current Ratio | 2.92% |
| Free Cash Flow | 141.78M |
Trending Stocks
Advertisement